Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Thyroid Neoplasms × Bexarotene × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Aggression 1

Interventions

durvalumab 1 Vemurafenib 1 Thyrotropin Alfa 1 Probiotics 1 Iodine-131 1 Bexarotene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00718770 2014-01-17

A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression

University of Colorado, Denver

Phase EARLY_PHASE1 Completed

10 enrolled 5 charts

Aggression, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡